BioCentury | Jul 18, 2005
Emerging Company Profile

Corporate Profile

...focus: Cancer Clinical status: Phase I/II Founded: 2003 through the merger of Cureon A/S and Pantheco A/S...
BioCentury | Jul 18, 2005
Emerging Company Profile

Santaris: Locking up RNA

...all therapeutic rights to LNA when it was formed through a merger of Cureon and Pantheco A/S...
BioCentury | Oct 20, 2003
Strategy

Tiny offspring

...Sput out from Exiqon in December 1999. Cureon, now called Santaris after its merger with Pantheco...
BioCentury | Oct 20, 2003
Strategy

Europe's spinning wheel

...a range of biochemical and biological properties suitable for antisense compounds. Cureon subsequently merged with Pantheco A/S...
...the fact that Cureon had technology but was was planning a new financing round, while Pantheco...
BioCentury | May 26, 2003
Company News

Cureon, Pantheco deal

...cash, which Santaris said should last two to three years. Santaris will be headquartered at Pantheco's...
...were in merger talks in March (see BioCentury, March 17). Cureon A/S , Copenhagen, Denmark Pantheco A/S...
BioCentury | May 26, 2003
Company News

Santaris management update

...CEO from CEO of Cureon A/S ; and Lars Tonnesen to CFO from CEO of Pantheco A/S...
BioCentury | Mar 17, 2003
Company News

Cureon, Pantheco deal

...Cureon said they are in merger talks. Cureon focuses on Locked Nucleic Acids (LNA), and Pantheco...
...four years. A final decision is expected in early April. Cureon A/S , Copenhagen, Denmark Pantheco A/S...
BioCentury | Mar 11, 2003
Company News

Pantheco, Cureon in merger discussions

...Cancer companies Pantheco (Copenhagen, Denmark) and Cureon (Copenhagen, Denmark) said they are in merger talks. Cureon's...
...are in merger talks. Cureon's technology is based on a Locked Nucleic Acids (LNA), and Pantheco...
BioCentury | Apr 2, 2001
Company News

Pantheco, Center for Genomics Research other research news

...HeLa cell cultures infected with the E. coli K12 strain without toxicity to mammalian cells. Pantheco A/S...
BioCentury | Jan 16, 2001
Company News

Pantheco, Zydus Cadila International Ltd. deal

...drugs. Zydus will undertake chemistry, preliminary screening and initial characterization of compounds with antibacterial activity. Pantheco...
...development. Each company will cover its own R&D costs, and profits will be shared 50-50. Pantheco A/S...
Items per page:
1 - 10 of 15
BioCentury | Jul 18, 2005
Emerging Company Profile

Corporate Profile

...focus: Cancer Clinical status: Phase I/II Founded: 2003 through the merger of Cureon A/S and Pantheco A/S...
BioCentury | Jul 18, 2005
Emerging Company Profile

Santaris: Locking up RNA

...all therapeutic rights to LNA when it was formed through a merger of Cureon and Pantheco A/S...
BioCentury | Oct 20, 2003
Strategy

Tiny offspring

...Sput out from Exiqon in December 1999. Cureon, now called Santaris after its merger with Pantheco...
BioCentury | Oct 20, 2003
Strategy

Europe's spinning wheel

...a range of biochemical and biological properties suitable for antisense compounds. Cureon subsequently merged with Pantheco A/S...
...the fact that Cureon had technology but was was planning a new financing round, while Pantheco...
BioCentury | May 26, 2003
Company News

Cureon, Pantheco deal

...cash, which Santaris said should last two to three years. Santaris will be headquartered at Pantheco's...
...were in merger talks in March (see BioCentury, March 17). Cureon A/S , Copenhagen, Denmark Pantheco A/S...
BioCentury | May 26, 2003
Company News

Santaris management update

...CEO from CEO of Cureon A/S ; and Lars Tonnesen to CFO from CEO of Pantheco A/S...
BioCentury | Mar 17, 2003
Company News

Cureon, Pantheco deal

...Cureon said they are in merger talks. Cureon focuses on Locked Nucleic Acids (LNA), and Pantheco...
...four years. A final decision is expected in early April. Cureon A/S , Copenhagen, Denmark Pantheco A/S...
BioCentury | Mar 11, 2003
Company News

Pantheco, Cureon in merger discussions

...Cancer companies Pantheco (Copenhagen, Denmark) and Cureon (Copenhagen, Denmark) said they are in merger talks. Cureon's...
...are in merger talks. Cureon's technology is based on a Locked Nucleic Acids (LNA), and Pantheco...
BioCentury | Apr 2, 2001
Company News

Pantheco, Center for Genomics Research other research news

...HeLa cell cultures infected with the E. coli K12 strain without toxicity to mammalian cells. Pantheco A/S...
BioCentury | Jan 16, 2001
Company News

Pantheco, Zydus Cadila International Ltd. deal

...drugs. Zydus will undertake chemistry, preliminary screening and initial characterization of compounds with antibacterial activity. Pantheco...
...development. Each company will cover its own R&D costs, and profits will be shared 50-50. Pantheco A/S...
Items per page:
1 - 10 of 15